Medicus Pharma Ltd. Common Stock (MDCXW) Stock Analysis & Investment Frameworks
Medicus Pharma Ltd. Common Stock (MDCXW) stock analysis on Invetso. Review Medicus Pharma Ltd. Common Stock’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Medicus Pharma Ltd. Common Stock Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: CA
Medicus Pharma Ltd. Common Stock Key Financial Metrics
- Market Cap: $2.95M
- Revenue: $N/A
- ROE: 17867.26%
- ROIC: -269.16%
- Dividend Yield: N/A
About Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.